We present a case of anti-aquaporin-4 antibody-positive myelitis, which suggests the high-risk syndrome of neuromyelitis optica, whose modest clinical signs were in conspicuous contrast to the extensive spinal cord lesions demonstrated on magnetic resonance (MR) imaging. Follow-up MR imaging showed marked improvement of lesions. Interestingly, an anti-glutamate receptor antibody, which has been suggested to cause dysfunction of Nmethy-D-aspartate receptor on neuron, was detected in the cerebrospinal ‰uid of the patient. We discuss the case and related literature.
Introduction
Myelitis with long spinal cord lesions extending more than 3 vertebral bones has recently been recognized as the high-risk syndrome of neuromyelitis optica (NMO). 1 NMO is a severe in‰ammatory demyelinating disorder that preferentially aŠects the optic nerves and spinal cord. The demonstration of antibody against water channel protein aquaporin-4 (AQP-4) in this syndrome underlies the view of this entity as an independent autoimmune disease. 2 The clinical presentation of NMO is generally severe because of its extensive spinal cord lesions. 1 We experienced a case of anti-AQP-4 antibodypositive myelitis with long spinal cord lesions that showed very modest clinical signs. Interestingly, anti-glutamate receptor antibody was found in the patient's cerebrospinal ‰uid (CSF).
Case Report
The patient was a 39-year-old woman with unremarkable medical history except for severe anterograde amnesia that was unresponsive to corticosteroid therapy. She also showed mild Hashimoto thyroiditis that did not require medication. We examined the patient to re-explore her amnesia, which had lasted 30 months. Neurological examination demonstrated di‹culty with delayed recall tasks. Magnetic resonance (MR) imaging of the brain disclosed lesions at the left caudate and left putamen. She was hospitalized in our department 3 weeks later.
On admission, the patient's consciousness was clear, but she was unable to maintain short term memory longer than 10 min. Neurological examination demonstrated faint exaggeration of the deep tendon re‰ex in her left upper and lower extremities and slight instability in tandem gait.
Neuropsychological examination disclosed severe impairment of the patient's short-term memory, demonstrated on Wechsler Memory ScaleRevised and by delayed reproduction task on Rey's Osterrieth Complex Figure. Other categories of cognitive function were not aŠected.
Two months later, MR imaging of the brain showed total disappearance of the lesions at the basal ganglia but a new lesion at left caudate body on T2-weighted (T2WI) and ‰uid-attentuated inversion-recovery (FLAIR) imaging. There was no contrast-enhanced lesion.
Laboratoryˆndings were unremarkable except for the presence of thyroid peroxidase antibody. Antinuclear, anti-neuronal, and anti-SS-A and SS-B antibodies were not detected. Although the level of thyroid-stimulating hormone was high, the concentration of thyroid hormone remained in normal range, and the clinical condition was similar to that 3 years previously. Examination of the CSF showed normal cell count (5/3 mL), mild elevation of pro- In accordance with her clinical history and repeated occurrence of multiple central nervous system lesions, we considered diagnosis of multiple sclerosis (MS). For thorough investigation of latent lesions, we performed MR imaging of her spinal cord, which demonstrated cervical and thoracic cord lesions that extended over more than 3 vertebral segments, involved gray and white matter, and were accompanied by cystic changes (Fig. 1  A-D) . Because longitudinal continuous lesions extending more than 3 vertebral segments are highly speciˆc to NMO, we tested her serum for anti-AQP-4 antibody 3 and found it. Exploring the etiology of the patient's amnesia, we checked for the presence of voltage-gated potassium channel (VGKC) and glutamate receptor e2 subunit (GluRe2). VGKC antibody was not detected, and anti-GluRe2 antibody was found to be positive not in the serum but in the cerebrospinal ‰uid.
We treated the patient with intravenous methylpredonisolone (1000 mg/day for 3 days per week), and the spinal cord lesions responded well. Except for cystic lesions, the cervical and thoracic spinal cord lesions disappeared almost completely after therapy. MR imaging with contrast enhancement showed no lesions. The neurological signs, modest hyper-re‰exia in her left side, and unsteady tandem gait also disappeared. However, the patient's amnesia remained unchanged. She was discharged after introduction of subcutaneous injection of interferon-beta.
One month later, the patient's short term memory started to improve, and follow-up examination 5 months later demonstrated that her memory function had returned to a normal level. Six months later, MR imaging study showed further improvement of the spinal cord lesions and almost complete disappearance of the cystic lesions ( Fig. 2 A-D) . 
Discussion
The diagnosis of myelitis was unexpected because the patient showed only faint clinical signs suggesting the condition. However, MR imaging of the spinal cord demonstrated ‰orid expression of lesions at both the cervical and thoracic cords. The long cord lesions that extended more than 3 vertebral segments and brain lesions that did not meet the radiological criteria for MS steered us toward the diagnosis of NMO. However, because we could not demonstrate optic neuritis, we could not diagnose NMO. Rather, because of the presence of both anti-AQP-4 and longitudinally extended spinal cord lesions, we considered the case to be at an early stage of and highly likely to develop into NMO, i.e., the high-risk syndrome of NMO. Applying a more sensitive AQP-4 assay system, Takahashi's group recently reported sensitivity of 85z and speciˆcity of 100z for anti-AQP-4 antibody assay for the high-risk syndrome. 1 The most interesting aspect of this case is the marked discrepancy between the extent of the spinal cord lesions and the severity of its clinical signs, which rated 1.0 on the expanded disability status scale (EDSS). The attacks of NMO are generally considered more severe than those typical of MS, and this was underscored in the diagnostic criteria proposed in 1999. 4 Our case revealed marked swelling of the spinal cord and cystic lesions compatible with severe in‰ammation. These MRˆndings suggest severe neurological deˆcit. In accordance with this idea, a recent study shows that data from 21 anti-AQP-4 antibody-positive cases distributed from 3.5 to 6.5 on EDSS, 1 which means the severity of our case must therefore be considered exceptionally mild.
The case presented here showed anti-GluRe2 antibody intrathecally. GluRe2 is a subunit of Nmethyl-D-aspartate (NMDA) receptor, which is predominantly expressed at the hippocampus and forebrain and is involved in memory function. The amnesia of our patient appears compatible with the diagnosis of limbic encephalitis associated with anti-GluRe2 antibody. Although a recent study demonstrated that some cases of paraneoplastic limbic encephalitis are associated with anti-GluRe2 antibody, 5 absence ofˆndings suggesting malignancy did not support diagnosis of paraneoplastic syndrome in our case. The diagnosis of Hashimoto encephalopathy, a still controversial entity, is not consistent with our case because the anterograde amnesia did not respond to corticosteroid therapy. 6 The reversibility of the amnesia suggests that the antibody is functionally active during episodes of myelitis. An NMDA receptor presents diŠusely in the gray matter of the human spinal cord. 7 Although the localization of NMDA receptor subtypes in the human spinal cord is still under debate, the existence of GluRe2 has, in fact, been shown in rodents.
If we consider that extensive in‰ammation with edema and necrosis with cystic changes or cavitation were commonly observed in spinal cord lesions occurring with NMO and that glutamate receptor is related to the induction of necrosis, then the remarkable discrepancy between neurological signs and severity of spinal cord lesions in this case suggests that the anti-glutamate receptor antibody might act protectively against myelitis. The shrinkage of the cavitary lesion without spinal cord atrophy on MR imaging might suggest that the nature of the lesion in our case is not cyst associated with pure necrosis but predominantly edema, though we cannot thoroughly exclude the possibility of imprecise estimation of the size of edema resulting from partial volume eŠect on MR imaging. This observation is consistent with our view that necrosis was halted by an unknown mechanism. The diŠerential diagnosis of spinal cord lesion is syringomyelia and spinal cord tumors. Since the best way to treat NMO has not been established, further progress will be expected.
